Matsubara, H., Fukuda, T., Awazu, Y., Nanno, S., Shimomura, M., Inoue, Y., . . . Sumi, T. (2021). PRMT1 expression predicts sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma. Oncol Lett.

Matsubara, Hiroaki, Takeshi Fukuda, Yuichiro Awazu, Shigenori Nanno, Masahiro Shimomura, Yuta Inoue, Makoto Yamauchi, Tomoyo Yasui, ja Toshiyuki Sumi. "PRMT1 Expression Predicts Sensitivity to Platinum-based Chemotherapy in Patients With Ovarian Serous Carcinoma." Oncol Lett 2021.

Matsubara, Hiroaki, et al. "PRMT1 Expression Predicts Sensitivity to Platinum-based Chemotherapy in Patients With Ovarian Serous Carcinoma." Oncol Lett 2021.